ArticleScientific reports2026
Machine learning prediction of common bile duct stones using synthetic data to guide emergency ERCP decisions.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Endoscopic retrograde cholangiopancreatography (ERCP) remains the standard for common bile duct (CBD) stone removal. However, current guidelines often result in unnecessary procedures. This study aimed to develop and validate a machine learning model using synthetic data augmentation to improve CBD stone prediction. Electronic health records from patients with suspected CBD stones were analyzed from three independent tertiary centers (733 patients for internal validation, 348 for external validation). A large language model (LLM) generated curated synthetic data to augment the training dataset. The ExtraTrees classifier was selected after evaluating multiple algorithms. Model performance was assessed using area under the receiver-operating characteristic curve (AUROC), calibration curves, and decision curve analysis. The model incorporated 11 routinely available variables and achieved an AUROC of 0.982 (95% CI 0.952-1.000) in internal validation and 0.957 (95% CI 0.937-0.974) in external validation. Compared to existing clinical guidelines, the model substantially reduced unnecessary ERCPs (0% vs 11.9-22.9% in internal validation; 6.7% vs 29.2-35.9% in external validation) while maintaining low false-negative rates (17.6% vs 28.2-45.6% in external validation). Calibration curves demonstrated good alignment between predicted and observed outcomes. Decision curve analysis confirmed greater net clinical benefit than existing guidelines. Feature importance analysis identified CBD dilatation ≥ 10 mm as the most influential predictor, followed by liver function parameters. This machine learning model, enhanced by LLM-generated synthetic data, significantly outperformed existing clinical guidelines for CBD stone prediction. The model provides a practical risk stratification tool using routinely available emergency department variables and may reduce unnecessary ERCP procedures while maintaining diagnostic safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.